Journal Article

Pegylated Interferon-α for Treating Chronic Hepatitis E Virus Infection after Liver Transplantation

Nassim Kamar, Lionel Rostaing, Florence Abravanel, Cyril Garrouste, Laure Esposito, Isabelle Cardeau-Desangles, Jean Michel Mansuy, Janick Selves, Jean Marie Peron, Philippe Otal, Fabrice Muscari and Jacques Izopet

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 50, issue 5, pages e30-e33
Published in print March 2010 | ISSN: 1058-4838
Published online March 2010 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/650488
Pegylated Interferon-α for Treating Chronic Hepatitis E Virus Infection after Liver Transplantation

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

This study assessed the effect of a 3-month course of pegylated interferon-α-2a (Peg-IFN-α-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after Peg-IFN-α-2a therapy was completed. A relapse was observed in the third patient.

Journal Article.  2065 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.